Raptakos Brett And Company Limited

Founded in 1930 and headquartered in Maharashtra, India.

1930 | Mumbai, Maharashtra (India) | Active
Last Updated: January 01, 2025

Raptakos Brett And Company Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 1.26 Cr
  • Company Age 94 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 244.50 Cr
  • Satisfied Charges ₹ 3.30 M

About Raptakos Brett And Company

Raptakos Brett And Company Limited (RBACL) was founded in India on 24 April 1930 and has a glorious history of 94 years and ten months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.26 Cr.

The company currently has active open charges totaling ₹244.50 Cr. The company has closed loans amounting to ₹3.30 M, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Raptakos Brett And Company Limited India is Hemant Dande as CEO. Indra Durlabhji, Ashok Bhave, Aruna Kanoria, and Two other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    raptakos.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U52310MH1930PLC002084

  • Company No.

    002084

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    24 Apr 1930

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Raptakos Brett And Company Limited offer?

Raptakos Brett And Company Limited offers a wide range of products and services, including Diabetes Medicine, Fitness Supplements, Calcium Tablet, Calcium Carbonate Tablet, Common Disease Medicines, IV Fluids, Nutraceuticals & Dietary Supplements, FRP Lining, PU & Powder Coatings, Spray Paints, Ayurvedic Medicine.

Who are the key members and board of directors at Raptakos Brett And Company?

Executive Team (1)

NameDesignationAppointment DateStatus
Hemant Dande CEO30-Jan-2024Current

Board Members (5)

NameDesignationAppointment DateStatus
Indra Durlabhji Country flag representing In Director 09-Sep-1996Current
Ashok Bhave Country flag representing In Additional Director 01-Jun-2024Current
Aruna Kanoria Country flag representing In Director 02-Mar-2015Current
Vijay Tagwale Country flag representing In Whole-Time Director 03-Nov-2020Current
Suhrud Jhaveri Country flag representing In Director 09-Sep-1996Current

Financial Performance of Raptakos Brett And Company.

Raptakos Brett And Company Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Raptakos Brett And Company?

In 2021, Raptakos Brett And Company had a promoter holding of 100.00%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹244.50 Cr

Satisfied Charges

₹0.33 Cr

Charges Breakdown by Lending Institutions

  • Citi Bank N.A. : 158.50 Cr
  • Standard Chartered Bank : 55.00 Cr
  • Hdfc Bank Limited : 31.00 Cr

Latest Charge Details

DateLenderAmountStatus
24 Dec 2021Citi Bank N.A.₹1.00 MOpen
06 Sep 2018Standard Chartered Bank₹55.00 CrOpen
05 Jun 2018Citi Bank N.A.₹158.40 CrOpen
05 Oct 2005Hdfc Bank Limited₹31.00 CrOpen
09 Mar 1988The Bank Of Rajasthan Ltd₹1.80 MSatisfied

How Many Employees Work at Raptakos Brett And Company?

Unlock and access historical data on people associated with Raptakos Brett And Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raptakos Brett And Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raptakos Brett And Company's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Raptakos Brett And Company

Recent activity within the organization

  • Annual General Meeting

    Raptakos Brett And Company Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Director Appointment

    Ashok Vishwanath Bhave was appointed as a Additional Director was appointed as a Additional Director on 01 Jun 2024 & has been associated with this company since 8 months 23 days .

    01 Jun 2024

  • Balance Sheet

    Raptakos Brett And Company Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Director Appointment

    Hemant Vasant Dande was appointed as a Ceo was appointed as a Ceo on 30 Jan 2024 & has been associated with this company since 1 year 24 days .

    30 Jan 2024

  • Charges

    A charge with Citi Bank N.A. amounted to Rs. 0.10 Cr with Charge ID 100552864 was registered on 24 Dec 2021.

    24 Dec 2021

  • Charges

    A charge registered on 09 Mar 1988 via Charge ID 90214336 with The Bank Of Rajasthan Ltd was fully satisfied on 24 Aug 2021.

    24 Aug 2021

Frequently asked questions

  • Raptakos Brett And Company Limited was incorporated on 24 Apr 1930.

  • The authorized share capital of Raptakos Brett And Company Limited is ₹ 10.00 Cr and paid-up capital is ₹ 1.26 Cr.

  • Currently 6 directors are associated with Raptakos Brett And Company Limited.

    • Indra Durlabhji
    • Ashok Vishwanath Bhave
    • Aruna Kantikumar Kanoria
    • Hemant Vasant Dande
    • Vijay Harishchandra Tagwale
    • Suhrud Shantilal Jhaveri
  • As per Ministry of Corporate Affairs (Mca), the registered address of Raptakos Brett And Company Limited is 253 Dr.Annie Besant Road, Worli Colony P.O. India, Mumbai- 400 030, Maharashtra, 400030.

  • The corporate identification number (CIN) of Raptakos Brett And Company Limited is U52310MH1930PLC002084 and the company number is 002084 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Raptakos Brett And Company Limited is https://www.raptakos.com

  • As per the financial statements for fiscal Year 2022, The total open charges for Raptakos Brett And Company Limited amount to ₹ 244.50 Cr.

  • The most recent Balance Sheet for Raptakos Brett And Company Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development